136 related articles for article (PubMed ID: 3747850)
1. Role of progestogens in the prevention of breast cancer.
Gambrell RD
Maturitas; 1986 Jul; 8(2):169-76. PubMed ID: 3747850
[TBL] [Abstract][Full Text] [Related]
2. Prevention of endometrial cancer with progestogens.
Gambrell RD
Maturitas; 1986 Jul; 8(2):159-68. PubMed ID: 3747849
[TBL] [Abstract][Full Text] [Related]
3. Decreased incidence of breast cancer in postmenopausal estrogen-progestogen users.
Gambrell RD; Maier RC; Sanders BI
Obstet Gynecol; 1983 Oct; 62(4):435-43. PubMed ID: 6888821
[TBL] [Abstract][Full Text] [Related]
4. Hormone replacement therapy in postmenopausal women: endometrial hyperplasia and irregular bleeding.
Lethaby A; Farquhar C; Sarkis A; Roberts H; Jepson R; Barlow D
Cochrane Database Syst Rev; 2000; (2):CD000402. PubMed ID: 10796715
[TBL] [Abstract][Full Text] [Related]
5. Estrogen therapy and breast cancer in postmenopausal women.
Gambrell RD; Massey FM; Castaneda TA; Boddie AW
J Am Geriatr Soc; 1980 Jun; 28(6):251-7. PubMed ID: 7372968
[TBL] [Abstract][Full Text] [Related]
6. Use of progestogen therapy.
Gambrell RD
Am J Obstet Gynecol; 1987 May; 156(5):1304-13. PubMed ID: 3578452
[TBL] [Abstract][Full Text] [Related]
7. The menopause: benefits and risks of estrogen-progestogen replacement therapy.
Gambrell RD
Fertil Steril; 1982 Apr; 37(4):457-74. PubMed ID: 7040116
[TBL] [Abstract][Full Text] [Related]
8. Hormones in the etiology and prevention of breast and endometrial cancer.
Gambrell RD
South Med J; 1984 Dec; 77(12):1509-15. PubMed ID: 6505760
[TBL] [Abstract][Full Text] [Related]
9. Oestrogen and progestogen hormone replacement therapy for peri-menopausal and post-menopausal women: weight and body fat distribution.
Norman RJ; Flight IH; Rees MC
Cochrane Database Syst Rev; 2000; (2):CD001018. PubMed ID: 10796730
[TBL] [Abstract][Full Text] [Related]
10. Proposal to decrease the risk and improve the prognosis of breast cancer.
Gambrell RD
Am J Obstet Gynecol; 1984 Sep; 150(2):119-32. PubMed ID: 6476033
[TBL] [Abstract][Full Text] [Related]
11. Role of hormones in the etiology and prevention of endometrial and breast cancer.
Gambrell RD
Acta Obstet Gynecol Scand Suppl; 1981; 106():37-46. PubMed ID: 7042835
[TBL] [Abstract][Full Text] [Related]
12. Use of hormone replacement therapy and risk of breast cancer: nested case-control studies using the QResearch and CPRD databases.
Vinogradova Y; Coupland C; Hippisley-Cox J
BMJ; 2020 Oct; 371():m3873. PubMed ID: 33115755
[TBL] [Abstract][Full Text] [Related]
13. Hormone replacement therapy and breast cancer.
Gambrell RD
Maturitas; 1987 Aug; 9(2):123-33. PubMed ID: 3309572
[TBL] [Abstract][Full Text] [Related]
14. Cancer and the use of estrogens.
Gambrell RD
Int J Fertil; 1986; 31(2):112-3, 116-22. PubMed ID: 2875032
[TBL] [Abstract][Full Text] [Related]
15. The prevention of endometrial cancer in postmenopausal women with progestogens.
Gambrell RD
Maturitas; 1978 Sep; 1(2):107-12. PubMed ID: 755956
[TBL] [Abstract][Full Text] [Related]
16. Re-evaluating the role of progestogen therapy after the menopause.
Henderson BE; Ross RK; Lobo RA; Pike MC; Mack TM
Fertil Steril; 1988 May; 49(5 Suppl 2):9S-15S. PubMed ID: 3360188
[TBL] [Abstract][Full Text] [Related]
17. Epidemiologic aspects of exogenous progestagens in relation to their role in pathogenesis of human breast cancer.
van Leeuwen FE
Acta Endocrinol (Copenh); 1991; 125 Suppl 1():13-26. PubMed ID: 1801500
[TBL] [Abstract][Full Text] [Related]
18. Tibolone: new preparation. Menopausal symptoms: oestrogen-progestogen combinations are still the reference treatment.
Prescrire Int; 2002 Jun; 11(59):79-82. PubMed ID: 12068842
[TBL] [Abstract][Full Text] [Related]
19. Cancer issues.
Marsden J; Sturdee D
Best Pract Res Clin Obstet Gynaecol; 2009 Feb; 23(1):87-107. PubMed ID: 19036643
[TBL] [Abstract][Full Text] [Related]
20. Is breast cancer risk the same for all progestogens?
Stute P
Arch Gynecol Obstet; 2014 Aug; 290(2):207-9. PubMed ID: 24838289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
